This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Spinal muscular atrophy type I

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Werdnig-Hoffman disease is an early infantile form of spinal muscular atrophy, with an autosomal recessive inheritance and is seen with an incidence of 1 in 20,000 births. The earliest feature may be decreased fetal movements during late pregnancy

  • infants with type 1 SMA, also known as Werdnig-Hoffman disease, present with hypotonia, poor head control and reduced or absent tendon reflexes prior to 6 months of age

SMA type 1

  • the mother of a Werdnig-Hoffman disease child may have noticed a lack of foetal movements

  • profound hypotonia can manifest as a "frogleg" posture when lying and poor to absent head control - weakness is maximal in the shoulder and hip girdle muscles

  • weakness in intercostal muscles, with relative sparing of the diaphragm, produces a bell-shaped chest and a pattern of paradoxical breathing sometimes referred to as "belly-breathing"
  • infants with type 1 SMA develop tongue and swallowing weakness and tongue fasciculations are often present

  • facial weakness does develop, although this is usually not manifest early in the course of the disease - as the tongue and pharyngeal muscles weaken, these infants are at risk of aspiration and failure to thrive. Infants with type 1 SMA usually develop respiratory failure prior to 2 years of life

  • reduced or absent tendon reflexes

  • occasionally there may be swelling of a limb; this is secondary to the inability of the infant to move it when lying on it

Notes:

  • term spinal muscular atrophy (SMA) refers to a group of genetic disorders all characterized by degeneration of anterior horn cells and resultant muscle atrophy and weakness
    • most common SMA, accounting for over 95% of cases, is an autosomal recessive disorder that results from a homozygous deletion or mutation in the 5q13 survival of motor neuron (SMN1) gene
  • clinical severity of SMA correlates inversely with SMN2 gene copy number and varies from an extreme weakness and paraplegia of infancy to a mild proximal weakness of adulthood

Reference;

  • Sugarman EA, et al. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens. Eur J Hum Genet. 2012; 20(1):27–32.
  • Kolb JS, Tissel SpinalJT. Muscular Atrophy. Neurol Clin. 2015 November ; 33(4): 831–846.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.